Connecting the dots...Provectus Biopharmaceuticals
Pages
(Move to ...)
Disclosures
The Blog
Current News
Archived News
Investment and Other Letters
Presentations
Blog Readership Statistics
About the Blogger
▼
Showing posts with label
Dr. Shari Pilon-Thomas PhD
.
Show all posts
Showing posts with label
Dr. Shari Pilon-Thomas PhD
.
Show all posts
November 8, 2016
SITC 2016, ABSTRACT: Intralesional injection with Rose Bengal and systemic chemotherapy induces anti-tumor immunity in a murine model of pancreatic cancer
›
Updated below: 11/8/16 {thrice}. Source link Intralesional injection with Rose Bengal and systemic chemotherapy induces anti-tumor immun...
October 4, 2016
Immunity
›
Edited (by me) image above; original image source Let us take as given, finally in and by 2016, that PV-10 (chemical small [but heavy] m...
September 26, 2016
SITC 2016: Intralesional injection with Rose Bengal and systemic chemotherapy induces anti-tumor immunity in a murine model of pancreatic cancer
›
Updated below: 9/26/16 {twice}, 9/28/16 and 9/30/16. Click to enlarge Updated (9/26/16): A ccording to the Pancreatic Cancer Action ...
April 21, 2016
Burning Down The House
›
Wikipedia's tumor infiltrating lymphocytes (TILs) page describes TILs as "a type of white blood cell found in tumors." It go...
June 26, 2015
Hypothesis: Intralesional PV10 induces systemic immunity in humans
›
Provectus issued a press release today and made an associated 8-K filing (that included another item) regarding Moffitt Cancer Center'...
May 15, 2015
Revolutionize, Perfect, Quintessential
›
In regards to PV-10, Moffitt Cancer has said over the last couple of years: Single Injection May Revolutionize Melanoma Treatment, Moffi...
November 6, 2014
"Together, these studies support the induction of increased tumor-specific immunity after co-inhibitory blockade in combination with IL PV-10 therapy."
›
Moffitt Cancer Center's PV-10-related abstract from the 29th annual meeting of the Society for Immunotherapy of Cancer ("SITC"...
September 21, 2014
Co-stimulatory & Co-inhibitory
›
Moffitt's PV-10 presentation at the 2014 annual meeting of the Society for Immunotherapy of Cancer ("SITC") is entitled Ef...
›
Home
View web version